Clarius Group, LLC Novartis Ag Transaction History

Clarius Group, LLC

  • $1.39 Billion
  • Q2 2024

A detailed history of Clarius Group, LLC transactions in Novartis Ag stock. As of the latest transaction made, Clarius Group, LLC holds 7,753 shares of NVS stock, worth $896,324. This represents 0.06% of its overall portfolio holdings.

Number of Shares
7,753
Previous 9,335 16.95%
Holding current value
$896,324
Previous $902,000 8.54%
% of portfolio
0.06%
Previous 0.06%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 11, 2024
SELL
$92.57 - $107.37 $146,445 - $169,859
-1,582 Reduced 16.95%
7,753 $825,000
Q1 2024

Apr 17, 2024
SELL
$95.27 - $108.47 $60,591 - $68,986
-636 Reduced 6.38%
9,335 $902,000
Q4 2023

Jan 29, 2024
SELL
$92.27 - $101.54 $2,399 - $2,640
-26 Reduced 0.26%
9,971 $1.01 Million
Q3 2023

Oct 19, 2023
SELL
$94.73 - $105.13 $17,525 - $19,449
-185 Reduced 1.82%
9,997 $1.02 Million
Q2 2023

Aug 09, 2023
BUY
$92.52 - $104.91 $43,761 - $49,622
473 Added 4.87%
10,182 $1.03 Million
Q1 2023

Apr 17, 2023
SELL
$80.03 - $92.81 $72,987 - $84,642
-912 Reduced 8.59%
9,709 $893,000
Q4 2022

Jan 25, 2023
BUY
$75.55 - $92.52 $154,046 - $188,648
2,039 Added 23.76%
10,621 $964,000
Q3 2022

Oct 24, 2022
SELL
$74.61 - $87.26 $38,946 - $45,549
-522 Reduced 5.73%
8,582 $652,000
Q2 2022

Aug 10, 2022
BUY
$80.52 - $93.75 $274,090 - $319,125
3,404 Added 59.72%
9,104 $770,000
Q4 2021

Feb 02, 2022
BUY
$79.7 - $88.13 $16,338 - $18,066
205 Added 3.73%
5,700 $499,000
Q3 2021

Oct 18, 2021
SELL
$81.78 - $95.14 $45,387 - $52,802
-555 Reduced 9.17%
5,495 $449,000
Q2 2021

Aug 06, 2021
BUY
$85.24 - $94.15 $46,285 - $51,123
543 Added 9.86%
6,050 $552,000
Q1 2021

Apr 27, 2021
SELL
$83.5 - $98.47 $12,191 - $14,376
-146 Reduced 2.58%
5,507 $471,000
Q4 2020

Jan 15, 2021
BUY
$78.07 - $94.43 $7,963 - $9,631
102 Added 1.84%
5,653 $534,000
Q3 2020

Oct 09, 2020
SELL
$82.14 - $91.0 $30,227 - $33,488
-368 Reduced 6.22%
5,551 $483,000
Q2 2020

Jul 08, 2020
SELL
$80.93 - $91.1 $566 - $637
-7 Reduced 0.12%
5,919 $517,000
Q1 2020

Apr 24, 2020
SELL
$70.67 - $99.01 $39,787 - $55,742
-563 Reduced 8.68%
5,926 $489,000
Q4 2019

Jan 22, 2020
SELL
$84.35 - $95.37 $88,904 - $100,519
-1,054 Reduced 13.97%
6,489 $614,000
Q3 2019

Oct 23, 2019
BUY
$85.54 - $94.26 $82,118 - $90,489
960 Added 14.58%
7,543 $655,000
Q2 2019

Aug 02, 2019
BUY
$75.4 - $92.8 $150,272 - $184,950
1,993 Added 43.42%
6,583 $601,000
Q1 2019

May 14, 2019
BUY
$75.32 - $86.15 $144,614 - $165,408
1,920 Added 71.91%
4,590 $441,000
Q4 2018

Feb 11, 2019
BUY
$73.66 - $82.02 $196,672 - $218,993
2,670 New
2,670 $229,000

Others Institutions Holding NVS

# of Institutions
1,426
Shares Held
138M
Call Options Held
1.48M
Put Options Held
1.54M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $249B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Clarius Group, LLC Portfolio

Follow Clarius Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarius Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clarius Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email